Investing Profile
Timothy Haines
InvestorVC
Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. at Abingworth
Your Intro Paths to Timothy Haines
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Timothy is a member of
Hotmail Network
5856 CONNECTIONS
MiOrden.com Network
917 CONNECTIONS
various Network
462 CONNECTIONS
Fs Medical Supplies Network
372 CONNECTIONS
INSEAD Network
250 CONNECTIONS
Find Timothy Haines on
cbCurrent Investing Position
Abingworth Managing Partner
Investment Range
$15.0M - $30.0M
Sweet Spot
$22.5M
Investments On Record
3
Current Fund Size
$465M
Timothy Haines is on these Sector & Stage Rankings
Timothy Haines's Investments On Record (3)
Sign in to see all 3 investments on record.
Sign in with Google →Timothy Haines's Experience
CEO MiOrden.comPresent
CEO Fs Medical SuppliesPresent
Managing Director and Executive Partner AbingworthPresent
Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. AbingworthPresent
Chairman and Managing Partner AbingworthPresent
Managing Partner AbingworthPresent
Partner AbingworthPresent
CEO Astex Pharmaceuticals, Inc. (US)Present
CEO Intervascular Inc. and Patient Monitoring Maquet Getinge GroupPresent
CEO HotmailPresent
Chair TenUPresent
Non Executive Chair IMU BiosciencesPresent
Advisory Board Member Oxford University InnovationPresent
Panel Member - Health Innovation Challenge Fund Wellcome TrustPresent
General Manager / VP R and D and Manufacturing Telectronics Pacing Systems, Inc.Present
General Manager Baxter International Inc.Present
CEO variousPresent
Timothy Haines's Education
INSEAD Master of Business Administration (MBA) Business Administration and Management, General
Investors who invest with Timothy Haines
Sign in with Google →Scouts & Angels Affiliated With Timothy Haines
Sign in with Google →